首页> 外文期刊>International Journal of Pharmaceutics >Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro/in-vivo evaluation
【24h】

Novel instantly-soluble transmucosal matrix (ISTM) using dual mechanism solubilizer for sublingual and nasal delivery of dapoxetine hydrochloride: In-vitro/in-vivo evaluation

机译:新型速溶透粘膜基质(ISTM),使用双机制增溶剂溶解盐酸达泊西汀的舌下和鼻腔:体外/体内评估

获取原文
获取原文并翻译 | 示例
           

摘要

Dapoxetine (D) suffers from poor oral bioavailability (42%) due to extensive first pass metabolism. The usefulness of transmucosal (sublingual and intranasal) drug delivery to improve bioavailability of D, a weak basic drug, has been hampered by its poor solubility in the neutral pH of the body fluids. In this study, instantly-soluble transmucosal matrices (ISTMs) of D, containing dual mechanism solubilizer (Pluronic F-127/citric acid mixture), were prepared by lyophilization technique to enhance matrix disintegration, dissolution and transmucosal permeation. The matrices were evaluated for in-vitro disintegration, wetting time, in-vitro dissolution, ex vivo transmucosal permeation, scanning electron microscopy and in-vivo studies. Dissolution studies confirmed the higher ability of ISTMs to enhance the early time point dissolution and maintain complete drug dissolution in pH 6.8 compared to conventional lyophilized matrices. The optimized ISTM gave approximately 77.54 and 88.40 folds increase of D dissolution after 1 and 3 min relative to the drug powder in pH 6.8. ISTMs containing the highest F127 concentration (2%) and the lowest gelatin and mannitol concentrations (1%) exhibited the shortest in-vitro disintegration times (< 10 s), the fastest dissolution in the neutral pH of body fluids (99% in 3 min) and the highest enhancement of transmucosal permeation. The relative bioavailabilities of D after sublingual and intranasal administration of ISTMs to rabbits were about 124.58% and 611.15%, respectively, in comparison to the oral market tablet. The significant increase of drug dissolution in nasal fluids, rapid permeation rate together with the improved bioavailability propose that ISTMs could be promising for intranasal delivery of drugs suffering from oral hepatic metabolism and have limited solubility in nasal fluids. (C) 2016 Elsevier B.V. All rights reserved.
机译:由于广泛的首过代谢,达泊西汀(D)的口服生物利用度较差(42%)。经粘膜(舌下和鼻内)给药改善D(一种弱碱性药物)的生物利用度的有效性因其在体液中性pH中的溶解度差而受到阻碍。在这项研究中,通过冻干技术制备了含有双重作用的增溶剂(Pluronic F-127 /柠檬酸混合物)的D速溶性透粘膜基质(ISTM),以增强基质的崩解,溶解和透粘膜渗透性。评价基质的体外崩解,润湿时间,体外溶解,离体透粘膜渗透,扫描电子显微镜和体内研究。溶出度研究证实,与传统的冻干基质相比,ITMS具有更高的增强早期时间点溶出并在pH 6.8下保持药物完全溶出的能力。相对于pH 6.8的药物粉末,经过优化的ISTM在1和3分钟后D溶出度增加了约77.54和88.40倍。包含最高F127浓度(2%)和最低明胶和甘露醇浓度(1%)的ISTM表现出最短的体外崩解时间(<10 s),在体液中性pH值中溶解最快(3分之99%)分钟)和最高的透粘膜渗透增强。与口服市售片剂相比,在舌下和鼻内给兔子施用ISTM后,D的相对生物利用度分别约为124.58%和611.15%。药物在鼻腔中的溶解度显着增加,快速的渗透速率以及更高的生物利用度表明,ISTMs有望用于鼻内递送患有口服肝代谢的药物,并且在鼻腔中的溶解度有限。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号